Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Azaya Therapeutics, Inc. Elects Ze’ev Shaked, Ph.D., to Board of Directors

Abstract:
Brings Track Record of Successful Product Commercialization

Azaya Therapeutics, Inc. Elects Ze’ev Shaked, Ph.D., to Board of Directors

SAN ANTONIO, TX | Posted on May 31st, 2007

Azaya Therapeutics, Inc. today announced the election of Dr. Ze'ev Shaked to its Board of Directors. Dr. Shaked has extensive managerial and pharmaceutical product development experience in commercializing new drug products. He most recently was President and CEO of Spherics, Inc., where he transformed the company into a product-driven company with an attractive product pipeline, and where he raised more than $25 million from the venture capital industry.

Prior to Spherics, Dr. Shaked was Chief Operating Officer of ILEX Oncology, Inc., in San Antonio, Texas. He was instrumental in ILEX obtaining ownership and FDA approval for CAMPATH and Clolar, two of its commercialized products. In addition, Dr. Shaked has held a number of senior research and development and corporate management positions at ImmuLogic Pharmaceutical Corporation, Berlex Biosciences, Inc., Triton Biosciences, Inc., CODON Corporation, and Chiron Corporation. He obtained his Ph.D. in Organic Chemistry and Applied Biochemistry from the Massachusetts Institute of Technology.

"Ze'ev Shaked has an outstanding track record in the biopharmaceutical industry and in overseeing the development of new drugs," said John Kerr, chairman of the board of Azaya. "His wealth of scientific experience will be invaluable in guiding the overall development of Azaya's pipeline of products."

####

About Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc., is an emerging nanotherapy company with an innovative technology platform – Protein Stabilized Nanoparticles – (PSNTM) designed to significantly improve the efficacy and safety of water insoluble pharmaceutical agents. Azaya is initially building an in-house pipeline of safer and more efficacious nanoparticle chemotherapy drug products. Azaya was granted a patent on this technology in February 2007.

For more information, please click here

Contacts:
Azaya Therapeutics, San Antonio
Michael T. Dwyer, 210-341-6600
or
Dublin & Associates
Eric Whittington, 210-227-0221, ext. 239

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

DNA Double Helix Does Double Duty in Assembling Arrays of Nanoparticles: Synthetic pieces of biological molecule form framework and glue for making nanoparticle clusters and arrays May 25th, 2015

Nanostructures Increase Corrosion Resistance in Metallic Body Implants May 24th, 2015

Iranian Scientists Use Magnetic Field to Transfer Anticancer Drug to Tumor Tissue May 24th, 2015

New Antibacterial Wound Dressing in Iran Can Display Replacement Time May 22nd, 2015

Announcements

Researchers find the 'key' to quantum network solution May 25th, 2015

One step closer to a single-molecule device: Columbia Engineering researchers first to create a single-molecule diode -- the ultimate in miniaturization for electronic devices -- with potential for real-world applications May 25th, 2015

DNA Double Helix Does Double Duty in Assembling Arrays of Nanoparticles: Synthetic pieces of biological molecule form framework and glue for making nanoparticle clusters and arrays May 25th, 2015

Engineering Phase Changes in Nanoparticle Arrays: Scientists alter attractive and repulsive forces between DNA-linked particles to make dynamic, phase-shifting forms of nanomaterials May 25th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Janusz Bryzek Joins MEMS Industry Group to Lead New TSensors Division - New Division will Focus on Accelerating Development of Emerging Ultra-high Volume Sensors Supporting Abundance, mHealth and IoT May 14th, 2015

Carbodeon Appoints Leading Industry Expert as Advisory Board Member May 7th, 2015

Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project